142 related articles for article (PubMed ID: 38518703)
21. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection.
Osumi H; Fujisaki J; Omae M; Shimizu T; Yoshio T; Ishiyama A; Hirasawa T; Tsuchida T; Yamamoto Y; Kawachi H; Yamamoto N; Igarashi M
Gastric Cancer; 2017 Jul; 20(4):663-670. PubMed ID: 27783167
[TBL] [Abstract][Full Text] [Related]
23. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
[TBL] [Abstract][Full Text] [Related]
24. Histopathology of the endoscopic esophagogastric junction in patients with gastroesophageal reflux disease.
Ringhofer C; Lenglinger J; Izay B; Kolarik K; Zacherl J; Eisler M; Wrba F; Chandrasoma PT; Cosentini EP; Prager G; Riegler M
Wien Klin Wochenschr; 2008; 120(11-12):350-9. PubMed ID: 18709523
[TBL] [Abstract][Full Text] [Related]
25. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
26. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
27. Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance.
Amano Y; Nakahara R; Yuki T; Murakami D; Ujihara T; Tomoyuki I; Sagami R; Suehiro S; Katsuyama Y; Hayasaka K; Harada H; Tada Y; Miyaoka Y; Fujishiro H
J Gastroenterol; 2019 Nov; 54(11):984-993. PubMed ID: 31240437
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis.
Lerut T; Coosemans W; Van Raemdonck D; Dillemans B; De Leyn P; Marnette JM; Geboes K
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1059-65; discussion 1065-6. PubMed ID: 8159027
[TBL] [Abstract][Full Text] [Related]
29. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases.
Streitz JM; Ellis FH; Gibb SP; Balogh K; Watkins E
Ann Surg; 1991 Feb; 213(2):122-5. PubMed ID: 1992937
[TBL] [Abstract][Full Text] [Related]
30. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
31. Circumferential distribution and clinical characteristics of esophageal cancer in lower esophagus: differences related to histological subtype.
Okada M; Ishimura N; Mikami H; Okimoto E; Oshima N; Miyaoka Y; Fujishiro H; Ishihara S; Kinoshita Y
Esophagus; 2019 Jan; 16(1):98-106. PubMed ID: 30145681
[TBL] [Abstract][Full Text] [Related]
32. The spectrum of carcinoma arising in Barrett's esophagus. A clinicopathologic study of 26 patients.
Smith RR; Hamilton SR; Boitnott JK; Rogers EL
Am J Surg Pathol; 1984 Aug; 8(8):563-73. PubMed ID: 6465417
[TBL] [Abstract][Full Text] [Related]
33. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus.
Weston AP; Krmpotich PT; Cherian R; Dixon A; Topalosvki M
Am J Gastroenterol; 1997 Mar; 92(3):407-13. PubMed ID: 9068459
[TBL] [Abstract][Full Text] [Related]
34. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M
World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
[TBL] [Abstract][Full Text] [Related]
35. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II).
Ruol A; Merigliano S; Baldan N; Santi S; Petrin GF; Bonavina L; Ancona E; Peracchia A
Dis Esophagus; 1997 Jul; 10(3):190-5. PubMed ID: 9280078
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
38. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
[TBL] [Abstract][Full Text] [Related]
39. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.
Dzinic SH; Mahdi Z; Bernardo MM; Vranic S; Beydoun H; Nahra N; Alijagic A; Harajli D; Pang A; Saliganan DM; Rahman AM; Skenderi F; Hasanbegovic B; Dyson G; Beydoun R; Sheng S
PLoS One; 2019; 14(4):e0215089. PubMed ID: 31002675
[TBL] [Abstract][Full Text] [Related]
40. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
